• Cyclosporin A: Mechanism, Applications, and Workflow in Rese

  2026-06-28

  Cyclosporin A is a potent cyclophilin inhibitor used for immunosuppression, apoptosis, and viral entry research. Its well-characterized mechanism and reproducible performance make it essential for modeling autoimmune and mitochondrial functions. This article details its biochemistry, protocol integration, and experimental boundaries.

• Enhancing Luteolin Bioavailability via P-gp Inhibition with

  2026-06-27

  This study introduces a novel self-microemulsifying drug delivery system (SME) loaded with luteolin, demonstrating a 29-fold increase in oral bioavailability by inhibiting P-glycoprotein (P-gp) efflux. The work provides a methodologically rigorous approach to overcoming absorption barriers for bioactive flavonoids, with direct implications for improving the pharmacokinetics of poorly soluble compounds.

• Bufalin as a Molecular Glue: Advanced Insights for Cancer Re

  2026-06-26

  Explore Bufalin, a cardiotonic steroid, as an advanced apoptosis inducer and molecular glue degrader in cancer research. This article offers a deep scientific analysis of its mechanisms, with a unique focus on practical assay implementation and the latest findings on STK33 targeting.

• Breast Cancer’s Dependence on MCL-1: Apoptotic Function Reve

  2026-06-26

  The referenced study clarifies that breast cancer cells’ reliance on MCL-1 stems from its canonical anti-apoptotic function rather than non-apoptotic roles. This distinction has significant impact on the design and application of selective MCL-1 inhibitors in cancer research, particularly for strategies aiming to induce apoptosis in MCL-1-dependent tumors.

• Caspase-8 Assays: Mechanistic Insight and Translational Leve

  2026-06-25

  This thought-leadership article integrates emerging mechanistic discoveries on caspase-8 in apoptosis and pyroptosis with strategic assay guidance for translational researchers. It contextualizes the Caspase-8 Fluorometric Assay Kit within the evolving landscape of programmed cell death research, referencing recent evidence and comparing assay solutions, while offering a forward-looking perspective on clinical and experimental implications.

• E-64d (SKU A1903): Optimizing Cysteine Protease Inhibition i

  2026-06-25

  This article provides biomedical researchers with scenario-driven guidance on using E-64d (SKU A1903) for consistent, high-quality cysteine protease inhibition in cell viability and apoptosis assays. Drawing on recent literature and practical workflow insights, it demonstrates how E-64d addresses common challenges in experimental design, protocol optimization, and data interpretation, while ensuring reproducibility and reliability.

• CRTC-CREB Axis Senses Proteotoxic Stress in Drosophila Model

  2026-06-24

  This study reveals that the CRTC-CREB transcriptional axis acts as a molecular sensor for proteotoxic stress in Drosophila, linking reactive oxygen species (ROS) and JNK signaling to increased CREB activity. The work highlights a potential therapeutic pathway for age-related and neurodegenerative protein aggregation diseases, providing a mechanistic basis for future drug repositioning and pharmacological screening.

• CH 223191 (SKU A8609): Reliable AhR Antagonist for Toxicolog

  2026-06-23

  This article delivers scenario-driven, evidence-based guidance on applying CH 223191 (SKU A8609) as a validated aryl hydrocarbon receptor antagonist in cell viability, proliferation, and cytotoxicity assays. Researchers will find practical protocol parameters, data-backed troubleshooting, and candid product selection advice for maximizing reproducibility and insight in AhR signaling studies.

• AO/PI Staining Solution: Transforming Cell Viability Analysi

  2026-06-23

  This thought-leadership article explores how the AO/PI Staining Solution, powered by advanced fluorescent DNA dyes, is redefining translational research in cell viability and cytotoxicity assessment. Leveraging mechanistic insights and referencing recent findings in diabetic nephropathy, we discuss best practices, competitive advantages, and strategic guidance for researchers seeking high-fidelity live/dead cell discrimination.

• Chlorin e6: Mechanistic Horizons in Translational Photodynam

  2026-06-22

  This article explores the mechanistic and translational dimensions of Chlorin e6 (Ce6) as a next-generation photosensitizer in photodynamic therapy (PDT). Integrating fresh insights from biomaterial science and antibacterial research, it offers strategic guidance for researchers aiming to bridge oncology and anti-infective innovation. By contextualizing recent advances—such as electrospun Ce6-conjugated scaffolds—the article sets a new benchmark for the design and deployment of Ce6 in complex preclinical and clinical paradigms.

• Boc-D-FMK in Translational Models: Beyond Apoptosis Assays

  2026-06-22

  Explore Boc-D-FMK, a leading pan-caspase inhibitor, and its advanced applications in translational apoptosis and inflammation research. This article uniquely bridges molecular mechanism, model selection, and assay optimization to empower experimental reproducibility.

• Disrupting 14-3-3:BAD Interactions for Colorectal Cancer The

  2026-06-21

  This study introduces a novel high-throughput screening platform to identify FDA-approved drugs capable of disrupting 14-3-3 protein and BAD interactions, a critical axis in colorectal cancer cell survival. The findings highlight the repurposing potential of terfenadine, penfluridol, and lomitapide as pro-apoptotic agents, offering a new direction for targeted colorectal cancer therapies.

• AO/PI Staining Solution: Fluorescent DNA Dyes for Precision

  2026-06-20

  AO/PI Staining Solution leverages dual fluorescent DNA dyes to deliver high-precision, interference-resistant live/dead cell discrimination in complex samples. Designed for fluorescence-based cell counting, it overcomes traditional viability assay limitations and streamlines workflows for translational research, including diabetic nephropathy studies.

• miR-196a Drives EAC Aggressiveness via MYC/TERT/NFκB Axis

  2026-06-19

  This study uncovers how microRNA 196a promotes the aggressiveness of esophageal adenocarcinoma by modulating the MYC/TERT/NFκB signaling axis. The findings highlight the mechanistic interplay between miR-196a, c-MYC accumulation, TERT upregulation, and NFκB activation, offering new avenues for targeted intervention in cancer research.

• AMPK–SQSTM1 Feedback Drives Antioxidant Defense in Metabolic

  2026-06-19

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, leading to the dual activation of AMPK and NFE2L2/NRF2 and enhanced antioxidant defenses in cancer cells. These findings illuminate critical mechanisms underlying metabolic adaptation and therapeutic resistance, with direct implications for targeting lysosomal pH and autophagy pathways in cancer research.

7098 records 11/474 page Previous Next First page 上5页 1112131415 下5页 Last page